Signaling mechanisms that regulate actin-based motility processes in the nervous systemMEYER, Gary; FELDMAN, Eva L.Journal of neurochemistry. 2002, Vol 83, Num 3, pp 490-503, issn 0022-3042, 14 p.Article

Insulin resistance in the nervous systemKIM, Bhumsoo; FELDMAN, Eva L.Trends in endocrinology and metabolism. 2012, Vol 23, Num 3, pp 133-141, issn 1043-2760, 9 p.Article

Insulin-Like Growth Factors in the Peripheral Nervous SystemSAKOWSKI, Stacey A; FELDMAN, Eva L.Endocrinology and metabolism clinics of North America (Print). 2012, Vol 41, Num 2, issn 0889-8529, vii, 375-393 [20 p.]Article

Substrate patterning: an emerging technology for the study of neuronal behaviorCOREY, Joseph M; FELDMAN, Eva L.Experimental neurology (Print). 2003, Vol 184, pp 89-96, issn 0014-4886, 8 p., SUP1Article

Minireview : Insulin-Like Growth Factors in the Peripheral Nervous SystemSULLIVAN, Kelli A; KIM, Bhumsoo; FELDMAN, Eva L et al.Endocrinology (Philadelphia). 2008, Vol 149, Num 12, pp 5963-5971, issn 0013-7227, 9 p.Article

Neuroinflammation, COX-2, and ALS: a dual role?CONSILVIO, Christopher; VINCENT, Andrea M; FELDMAN, Eva L et al.Experimental neurology (Print). 2004, Vol 187, Num 1, pp 1-10, issn 0014-4886, 10 p.Article

Insulin-like growth factor-I signaling in human neuroblastoma cellsBHUMSOO KIM; VAN GOLEN, Cynthia M; FELDMAN, Eva L et al.Oncogene (Basingstoke). 2004, Vol 23, Num 1, pp 130-141, issn 0950-9232, 12 p.Article

Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cellsKIM, Bhumsoo; VAN GOLEN, Cynthia M; FELDMAN, Eva L et al.Endocrinology (Philadelphia). 2005, Vol 146, Num 12, pp 5350-5357, issn 0013-7227, 8 p.Article

Diabetic neuropathiesLITTLE, Ann A; EDWARDS, James L; FELDMAN, Eva L et al.Practical neurology (Print). 2007, Vol 7, Num 2, pp 82-92, issn 1474-7758, 11 p.Article

Insulin-like growth factor I stimulates motility in human neuroblastoma cellsMEYER, Gary E; SHELDEN, Eric; KIM, Bhumsoo et al.Oncogene (Basingstoke). 2001, Vol 20, Num 51, pp 7542-7550, issn 0950-9232Article

Transcriptional Profiling of Diabetic Neuropathy in the BKS db/db Mouse: A Model of Type 2 DiabetesPANDE, Manjusha; HUR, Junguk; YU HONG et al.Diabetes (New York, NY). 2011, Vol 60, Num 7, pp 1981-1989, issn 0012-1797, 9 p.Article

Dyslipidemia-Induced Neuropathy in Mice: The Role of oxLDL/LOX-1VINCENT, Andrea M; HAYES, John M; MCLEAN, Lisa L et al.Diabetes (New York, NY). 2009, Vol 58, Num 10, pp 2376-2385, issn 0012-1797, 10 p.Article

Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes MellitusPOP-BUSUI, Rodica; LOW, Philip A; WABERSKI, Barbara H et al.Circulation (New York, N.Y.). 2009, Vol 119, Num 22, pp 2886-2893, issn 0009-7322, 8 p.Article

Kindlin-2 Is an Essential Component of Intercalated Discs and Is Required for Vertebrate Cardiac Structure and FunctionDOWLING, James J; GIBBS, Elizabeth; RUSSELL, Mark et al.Circulation research. 2008, Vol 102, Num 4, pp 423-431, issn 0009-7330, 9 p.Article

Strategic approaches to developing drug treatments for ALSVINCENT, Andrea M; SAKOWSKI, Stacey A; SCHUYLER, Adam et al.Drug discovery today. 2008, Vol 13, Num 1-2, pp 67-72, issn 1359-6446, 6 p.Article

Remote delivery of rAAV-GFP to the rat brainstem through the recurrent laryngeal nerveRUBIN, Adam D; HOGIKYAN, Norman D; SULLIVAN, Kelli et al.The Laryngoscope. 2001, Vol 111, Num 11, pp 2041-2045, issn 0023-852X, 1Article

Intraspinal Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: A Phase I Safety Trial, Technical Note, and Lumbar Safety OutcomesRILEY, Jonathan; FEDERICI, Thais; POLAK, Meraida et al.Neurosurgery. 2012, Vol 71, Num 2, pp 405-416, issn 0148-396X, 12 p.Article

Hyperinsulinemia Induces Insulin Resistance in Dorsal Root Ganglion NeuronsKIM, Bhumsoo; MCLEAN, Lisa L; PHILIP, Stephen S et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 10, pp 3638-3647, issn 0013-7227, 10 p.Article

Abnormal Muscle Spindle Innervation and Large-Fiber Neuropathy in Diabetic MiceMULLER, Karra A; RYALS, Janelle M; FELDMAN, Eva L et al.Diabetes (New York, NY). 2008, Vol 57, Num 6, pp 1693-1701, issn 0012-1797, 9 p.Article

Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathyHONGYU ZHANG; SAHA, Jharna; BYUN, Jaeman et al.American journal of physiology. Renal physiology. 2008, Vol 64, Num 4, issn 1931-857X, F1071-F1081Article

Lifestyle intervention for pre-diabetic neuropathySMITH, A. Gordon; RUSSELL, James; ROBINSON SINGLETON, J et al.Diabetes care. 2006, Vol 29, Num 6, pp 1294-1299, issn 0149-5992, 6 p.Article

N-Myc overexpression leads to decreased β1 integrin expression and increased apoptosis in human neuroblastoma cellsVAN GOLEN, Cynthia M; SOULES, Mary E; GRAUMAN, Alyssa R et al.Oncogene (Basingstoke). 2003, Vol 22, Num 17, pp 2664-2673, issn 0950-9232, 10 p.Article

Schwann cell caveolin-1 expression increases during myelination and decreases after axotomyMIKOL, Daniel D; SCHERER, Steven S; DUCKETT, Sara J et al.Glia (New York, NY. Print). 2002, Vol 38, Num 3, pp 191-199, issn 0894-1491Article

PTEN/NMAC1 overexpression decreases insulin-like growth factor-1-mediated protection from apoptosis in neuroblastoma cellsVAN GOLEN, Cynthia M; SCHWAB, Tracy S; IGNATOSKI, Kathleen M et al.Cell growth and differentiation. 2001, Vol 12, Num 7, pp 371-378, issn 1044-9523Article

The Management of Diabetic Neuropathy in CKDPOP-BUSUI, Rodica; ROBERTS, Laurel; PENNATHUR, Subramaniam et al.American journal of kidney diseases. 2010, Vol 55, Num 2, pp 365-385, issn 0272-6386, 21 p.Article